The identified compound KL1 sensitizes intracellular bacteria to antibiotic killing by reducing the production of reactive species upon infection, presumably by targeting the EHMT2/G9a activity
Neri D, Steele EM, Khandpur N, Cediel G, Zapata ME, Rauber F, et al
To have a side effect to that is contradictory to how your biochemistry naturally works
The cells from Method 1 generally demonstrated a mild and slow change in morphology
These included: 11 opioid peptide studies (Table 1) and 6 publications on dietary interventions (Table 2), including one cohort with longitudinal follow-up data (Knivsberg et al
SeekPeptides provides tracking tools and protocol resources for members working with various peptide compounds, supporting organized documentation of research outcomes